Clinical Trial Update: Pharmacokinetics and Pharmacodynamics Study [Phase 1]

View source ↗

Summary

Qilu Pharmaceutical is conducting a Phase 1 pharmacokinetics and pharmacodynamics study for a hyperlipidemia program; the trial is not yet recruiting. This upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Hyperlipidemia
• Hypercholesterolemia

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C | Phase 1 | Status: NOT_YET_RECRUITING